ZetrOZ manufactures non-invasive medical devices that accelerate tissue healing and relieve pain through wearable bioelectronic technology for sustained acoustic medicine delivery. The product line treats acute and chronic musculoskeletal conditions by delivering therapeutic ultrasound to enhance tissue recovery. Founded in 2009 and headquartered in Trumbull, United States, ZetrOZ has raised approximately $6.8M in Series A funding from investors including Connecticut Innovations, NIH, and Mass Medical Angels. The company's sustained acoustic medicine technology provides an alternative to pharmaceutical pain management, delivering controlled ultrasound therapy through wearable devices that patients can use at home for treating conditions including tendonitis, arthritis, and muscle injuries.
← All startups
ZetrOZ
Series AZetrOZ manufactures non-invasive medical devices that accelerate tissue healing and relieve pain through wearable bioelectronic technology for sustained acoustic medicine delivery. The product line treats acute and chronic musculoskeletal conditions by delivering therapeutic ultrasound to enhance tissue recovery. Founded in 2009 and headquartered in Trumbull, United States, ZetrOZ has raised approximately $6.8M in…
About
Business model
Wearable Technology > Health and Wellness Devices > Chronic Pain,
Disease Self Management > Pain > Therapy > Chronic Pain > Device
Institutional investors
Connecticut InnovationsAzoic VenturesNSBRIAngel Investor ForumMass Medical AngelsBoston Harbor AngelsLaunchpad Venture GroupHorizonNIHHHSStonehenge CapitalEDGE Advisers
Latest coverage
📰 See all funding news — keep up with the raises that set comps.
Investor directory
🗂️ See who's investing in High Tech — full fund directory with check size and geography.